Rosario Pedro Weslley, Ward Laura Sterian, Graf Hans, Vaisman Fernanda, Mourão Gabriela Franco, Vaisman Mario
Santa Casa de Belo Horizonte, Minas Gerais, MG, Brasil.
Faculdade de Ciências Médicas da Universidade Estadual de Campinas (Unicamp), São Paulo, SP, Brasil.
Arch Endocrinol Metab. 2019 Sep 2;63(5):456-461. doi: 10.20945/2359-3997000000166. eCollection 2019.
The indolent evolution of low-risk papillary thyroid microcarcinoma (mPTC) in adult patients and the consequences of thyroidectomy require a revision of the management traditionally recommended. Aiming to spare patients unnecessary procedures and therapies and to optimize the health system in Brazil, we suggest some measures. Fine-needle aspiration of nodules ≤ 1 cm without extrathyroidal extension on ultrasonography should be performed only in nodules classified as "very suspicious" (i.e., high suspicion according to ATA, high risk according to AACE, TI-RADS 5) and in selected cases [age < 40 years, nodule adjacent to the trachea or recurrent laryngeal nerve (RLN), multiple suspicious nodules, presence of hypercalcitoninemia or suspicious lymph nodes]. Active surveillance (AS) rather than immediate surgery should be considered in adult patients with low-risk mPTC. Lobectomy is the best option in patients with unifocal low-risk mPTC who are not candidates for AS because of age, proximity of the tumor to the trachea or RLN, or because they opted for surgery. The same applies to patients who started AS but had a subsequent surgical indication not due to a suspicion of tumor extension beyond the gland or multicentricity. Molecular tests are not necessary to choose between AS and surgery or, in the latter case, between lobectomy and total thyroidectomy. The presence of RAS or other RAS-like mutations or BRAFV600E or other BRAF V600E-like mutations should not modify the management cited above; however, the rare cases of mPTC exhibiting high-risk mutations, like in the TERT promoter or p53, are not candidates for AS.
成年患者中低风险甲状腺微小乳头状癌(mPTC)的惰性进展以及甲状腺切除的后果,需要对传统推荐的管理方法进行修订。为了避免患者接受不必要的手术和治疗,并优化巴西的医疗体系,我们提出一些措施。对于超声检查显示直径≤1 cm且无甲状腺外侵犯的结节,仅应对分类为“高度可疑”(即根据美国甲状腺协会为高可疑,根据美国临床内分泌医师协会为高风险,TI-RADS 5类)的结节以及特定情况(年龄<40岁、结节紧邻气管或喉返神经(RLN)、多个可疑结节、存在降钙素血症或可疑淋巴结)进行细针穿刺。对于低风险mPTC的成年患者,应考虑采取主动监测(AS)而非立即手术。对于因年龄、肿瘤与气管或RLN的距离等原因不适合AS或选择手术的单灶低风险mPTC患者,肺叶切除术是最佳选择。对于开始AS但随后出现手术指征(并非怀疑肿瘤超出腺体或多中心性)的患者也是如此。在选择AS与手术之间,或者在后一种情况下,在肺叶切除术与全甲状腺切除术之间,分子检测并非必需。RAS或其他类似RAS的突变、BRAFV600E或其他类似BRAF V600E的突变的存在不应改变上述管理方法;然而,mPTC中表现出高风险突变(如TERT启动子或p53中的突变)的罕见病例不适合AS。